Verlaan M - Search Results

1

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [⁸⁹Zr]Zr-DFO-PEG₅-Tz.

Lumen D, Vugts D, Chomet M, Imlimthan S, Sarparanta M, Vos R, Schreurs M, Verlaan M, Lang PA, Hippeläinen E, Beaino W, Windhorst AD, Airaksinen AJ. Lumen D, et al. Among authors: verlaan m. Bioconjug Chem. 2022 May 18;33(5):956-968. doi: 10.1021/acs.bioconjchem.2c00164. Epub 2022 Apr 20. Bioconjug Chem. 2022. PMID: 35442642 Free PMC article.

2

In-vivo monitoring of anti-folate therapy in arthritic rats using [¹⁸F]fluoro-PEG-folate and positron emission tomography.

Chandrupatla DMSH, Jansen G, Vos R, Verlaan M, Chen Q, Low PS, Windhorst AD, Lammertsma AA, van der Laken CJ, Molthoff CFM. Chandrupatla DMSH, et al. Among authors: verlaan m. Arthritis Res Ther. 2017 May 31;19(1):114. doi: 10.1186/s13075-017-1325-x. Arthritis Res Ther. 2017. PMID: 28569209 Free PMC article.

3

Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P_1-7.

Pekošak A, Bulc JŽ, Korat Š, Schuit RC, Kooijman E, Vos R, Rongen M, Verlaan M, Takkenkamp K, Beaino W, Poot AJ, Windhorst AD. Pekošak A, et al. Among authors: verlaan m. Mol Pharm. 2018 Nov 5;15(11):4872-4883. doi: 10.1021/acs.molpharmaceut.8b00518. Epub 2018 Oct 25. Mol Pharm. 2018. PMID: 30335399 Free PMC article.

4

High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model.

Feroldi F, Verlaan M, Knaus H, Davidoiu V, Vugts DJ, van Dongen GAMS, Molthoff CFM, de Boer JF. Feroldi F, et al. Among authors: verlaan m. Biomed Opt Express. 2018 Nov 13;9(12):6186-6204. doi: 10.1364/BOE.9.006186. eCollection 2018 Dec 1. Biomed Opt Express. 2018. PMID: 31065422 Free PMC article.

5

Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical ⁸⁹Zr-immuno-PET.

Chomet M, Schreurs M, Bolijn MJ, Verlaan M, Beaino W, Brown K, Poot AJ, Windhorst AD, Gill H, Marik J, Williams S, Cowell J, Gasser G, Mindt TL, van Dongen GAMS, Vugts DJ. Chomet M, et al. Among authors: verlaan m. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):694-707. doi: 10.1007/s00259-020-05002-7. Epub 2020 Sep 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 32889615 Free PMC article.

6

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of ¹⁸F and ⁸⁹Zr as compared with ex vivo biodistribution in tumor-bearing mice.

Chomet M, Schreurs M, Vos R, Verlaan M, Kooijman EJ, Poot AJ, Boellaard R, Windhorst AD, van Dongen GA, Vugts DJ, Huisman MC, Beaino W. Chomet M, et al. Among authors: verlaan m. EJNMMI Res. 2021 Jun 12;11(1):57. doi: 10.1186/s13550-021-00799-2. EJNMMI Res. 2021. PMID: 34117946 Free PMC article.

7

Synthesis and evaluation of [¹⁸F]cinacalcet for the imaging of parathyroid hyperplasia.

Pees A, Beaino W, Kooijman EJM, Schreurs M, Verlaan M, Schuit RC, Vosjan MJWD, Engelsman AF, Windhorst AD, Vugts DJ. Pees A, et al. Among authors: verlaan m. Nucl Med Biol. 2021 Nov-Dec;102-103:97-105. doi: 10.1016/j.nucmedbio.2021.10.003. Epub 2021 Oct 29. Nucl Med Biol. 2021. PMID: 34743064 Free article.

8

Synthesis and preclinical evaluation of [¹¹C]LR111 and [¹⁸F]EW-7197 as PET tracers of the activin-receptor like kinase-5.

Rotteveel L, Kurakula K, Kooijman EJM, Schuit RC, Verlaan M, Schreurs M, Beaino W, van Dinther MAH, Ten Dijke P, Lammertsma AA, Poot AJ, Bogaard HJ, Windhorst AD. Rotteveel L, et al. Among authors: verlaan m. Nucl Med Biol. 2022 Sep-Oct;112-113:9-19. doi: 10.1016/j.nucmedbio.2022.05.003. Epub 2022 May 24. Nucl Med Biol. 2022. PMID: 35660796 Free article.

9

Advancing ⁸⁹Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential.

Wuensche TE, Stergiou N, Mes I, Verlaan M, Schreurs M, Kooijman EJM, Janssen B, Windhorst AD, Jensen A, Asuni AA, Bang-Andersen B, Beaino W, Dongen GAMS, Vugts DJ. Wuensche TE, et al. Among authors: verlaan m. Theranostics. 2022 Oct 9;12(16):7067-7079. doi: 10.7150/thno.73509. eCollection 2022. Theranostics. 2022. PMID: 36276653 Free PMC article.

10

Application of ⁸⁹Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody.

Stergiou N, Wuensche TE, Schreurs M, Mes I, Verlaan M, Kooijman EJM, Windhorst AD, Helboe L, Vergo S, Christensen S, Asuni AA, Jensen A, Van Dongen GAMS, Bang-Andersen B, Vugts DJ, Beaino W. Stergiou N, et al. Among authors: verlaan m. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1306-1317. doi: 10.1007/s00259-023-06109-3. Epub 2023 Jan 13. Eur J Nucl Med Mol Imaging. 2023. PMID: 36635462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page